Ge Li melds WuXi VC with Frontline, creating an $800M trans-Pacific powerhouse fund now hunting fresh biotech capital
WuXi’s Ge Li is leveraging up a whole new biotech venture group with ambitious plans to add to the hundreds of millions of dollars it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
